[Acute hemolytic anemia in Clostridium perfringens infection]

E H Duun1, I M Schiødt, O J Bergmann

  • 1Medicinsk haematologisk afdeling L, Amtssygehuset i Herlev.

Ugeskrift for Laeger
|August 6, 1999
PubMed

Insights

Clostridium perfringens can cause rare hemolytic anemia in cancer patients. This case highlights the first survival of multiple myeloma with C. perfringens septicemia, acute hemolysis, and anuria, suggesting penicillin treatment.

Area of Science:

  • Hematology
  • Infectious Diseases
  • Oncology

Background:

  • Clostridium perfringens-induced hemolytic anemia is a rare complication in patients with neoplastic diseases.
  • Malignancy, particularly multiple myeloma, presents unique challenges in managing severe infections.

Observation:

  • A patient with multiple myeloma developed Clostridium perfringens septicemia.
  • The patient experienced acute hemolytic anemia and acute anuria concurrently with the septicemia.

Findings:

  • This case represents the first documented survival of a patient with multiple myeloma experiencing C. perfringens septicemia complicated by acute hemolysis and anuria.
  • Prompt administration of penicillin was crucial in the patient's recovery.

Implications:

  • Penicillin should be considered for febrile patients with acute hemolytic anemia when no other cause is evident.
  • Early recognition and treatment of C. perfringens infections in immunocompromised patients are critical for survival.

Related Concept Videos

Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Inhalation Anthrax01:25

Inhalation Anthrax

Anthrax is a zoonotic disease caused by Bacillus anthracis, a Gram-positive, spore-forming bacterium. It primarily affects herbivorous animals but can be transmitted to humans through skin contact, ingestion, or inhalation of spores.Cutaneous anthrax, the most common form, typically results from direct contact with bacterial spores through skin abrasions and is generally less severe. Gastrointestinal anthrax results from eating undercooked or contaminated meat. It affects the mouth, throat, or...